Biotherapeutics Division, National Institute for Biological Standards and Control, South Mimms, UK.
J Thromb Haemost. 2022 Feb;20(2):498-507. doi: 10.1111/jth.15555. Epub 2021 Nov 24.
D-dimer antigen is a heterogeneous mixture of fibrin degradation products that when present at high levels in plasma indicate ongoing coagulation and fibrinolysis. The heterogeneous nature of the target D-dimer antigen and the variety of assay systems means that it is difficult to compare results from different methods.
To identify a universally agreed D-dimer standard that could help harmonize results from different methods.
A pool of patient plasma with high D-dimer levels was freeze-dried and investigated as a long-term World Health Organization international standard for D-dimer. Fibrin degradation products from clot lysis reactions were also freeze-dried in various formulations and investigated in commutability studies with patient plasma.
Problems of instability of D-dimer plasma emerged suggesting loss of reactivity after freeze-drying and storage at -20°C of 10%-18% per year. Freeze-dried fibrin degradation products added to plasma were also unstable, but the sugar trehalose was found to improve stability. However, this preparation was not suitable as a standard in widely used assay platforms. Previous studies suggest fibrin degradation products are prone to structural rearrangements and amyloid formation, which may explain the instability of candidate D-dimer standards.
The known difficulties of D-dimer standardization are compounded by instability of D-dimer antigen after freeze-drying, described in this report. Fibrin degradation products added to plasma and stabilized by trehalose are not suitable as a standard for D-dimer measurement harmonization. Trehalose stabilization of pooled patient plasma containing high D-dimer levels may produce a useful standard, but this requires confirmation.
D-二聚体抗原是纤维蛋白降解产物的异质混合物,当在血浆中高水平存在时,表明正在进行凝血和纤维蛋白溶解。目标 D-二聚体抗原的异质性和各种检测系统意味着很难比较来自不同方法的结果。
确定一种普遍认可的 D-二聚体标准,以帮助协调来自不同方法的结果。
将高 D-二聚体水平的患者血浆冻干并研究作为长期世界卫生组织 D-二聚体国际标准。还将纤维蛋白溶解反应中的纤维蛋白降解产物冻干在各种配方中,并在与患者血浆的可比性研究中进行研究。
出现 D-二聚体血浆不稳定性问题,表明冻干后和在-20°C下储存时每年损失 10%-18%的反应性。添加到血浆中的冻干纤维蛋白降解产物也不稳定,但发现糖海藻糖可提高稳定性。然而,该制剂不适合在广泛使用的检测平台中作为标准。先前的研究表明纤维蛋白降解产物容易发生结构重排和淀粉样形成,这可能解释了候选 D-二聚体标准的不稳定性。
本报告描述了冻干后 D-二聚体抗原不稳定性加剧了 D-二聚体标准化的已知困难。添加到血浆中并通过海藻糖稳定的纤维蛋白降解产物不适合作为 D-二聚体测量协调的标准。含有高 D-二聚体水平的混合患者血浆的海藻糖稳定可能产生有用的标准,但这需要确认。